Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage.
Clin Microbiol Infect
; 13(8): 836-8, 2007 Aug.
Article
en En
| MEDLINE
| ID: mdl-17501976
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Tuberculosis
/
Interferón gamma
Tipo de estudio:
Diagnostic_studies
/
Evaluation_studies
/
Incidence_studies
/
Risk_factors_studies
Límite:
Child
/
Humans
País como asunto:
Europa
Idioma:
En
Año:
2007
Tipo del documento:
Article